Literature DB >> 11233775

6-Phosphogluconate dehydrogenase deficiency in an Italian family.

P Caprari1, M P Caforio, P Cianciulli, D Maffi, M T Pasquino, A Tarzia, S Amadori, A M Salvati.   

Abstract

A rare case of hereditary erythrocyte enzymopathy, namely 6-phosphogluconate dehydrogenase (6PGD) deficiency, was found in an Italian family. The activity of the enzyme was reduced to 35% in the propositus and her mother, but was normal in the other three members of the family. The 6PGD deficiency was associated with a variable reticulocyte count and recurrent increased unconjugated bilirubinemia without anemia in the propositus, while no clinical or hematological symptoms were evident in her mother. Increased levels of erythrocyte pyruvate kinase (PK) activity and reduced glutathione (GSH) were observed, indicating a slight decrease in mean red blood cell (RBC) age and an activation of reducing systems. The episodic hemolytic events with jaundice observed in the propositus may be the result of a defective RBC ability to counteract conditions of marked oxidative stress. In this report the importance of 6PGD estimation for a proper analysis of glucose-6-phosphate dehydrogenase (G6PD) deficiency is also highlighted. In fact in the present study, the presence of 6PGD deficiency could be mistaken for a partial G6PD deficiency if the assay of G6PD activity was performed without correcting for 6PGD activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11233775     DOI: 10.1007/s002770000233

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  9 in total

Review 1.  Radical induction theory of ulcerative colitis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

2.  False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency.

Authors:  Grace Stuhrman; Stefanie J Perez Juanazo; Kea Crivelly; Jennifer Smith; Hans Andersson; Eva Morava
Journal:  JIMD Rep       Date:  2017-01-12

3.  Functional constraints of 6-phosphogluconate dehydrogenase (6-PGD) based on sequence and structural information.

Authors:  George N Goulielmos; Elias Eliopoulos; Michael Loukas; Spyros Tsakas
Journal:  J Mol Evol       Date:  2004-09       Impact factor: 2.395

4.  Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes.

Authors:  G P Laliotis; I Bizelis; E Rogdakis
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

Review 5.  Metabolic theory of septic shock.

Authors:  Jay Pravda
Journal:  World J Crit Care Med       Date:  2014-05-04

6.  Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.

Authors:  S Elf; R Lin; S Xia; Y Pan; C Shan; S Wu; S Lonial; M Gaddh; M L Arellano; H J Khoury; F R Khuri; B H Lee; T J Boggon; J Fan; J Chen
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

Review 7.  The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.

Authors:  Anna Stincone; Alessandro Prigione; Thorsten Cramer; Mirjam M C Wamelink; Kate Campbell; Eric Cheung; Viridiana Olin-Sandoval; Nana-Maria Grüning; Antje Krüger; Mohammad Tauqeer Alam; Markus A Keller; Michael Breitenbach; Kevin M Brindle; Joshua D Rabinowitz; Markus Ralser
Journal:  Biol Rev Camb Philos Soc       Date:  2014-09-22

8.  Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1.

Authors:  Weiwei He; Yi Wang; Wei Liu; Cong-Zhao Zhou
Journal:  BMC Struct Biol       Date:  2007-06-14

9.  Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming.

Authors:  Haymanti Bhanot; Ellen L Weisberg; Mamatha M Reddy; Atsushi Nonami; Donna Neuberg; Richard M Stone; Klaus Podar; Ravi Salgia; James D Griffin; Martin Sattler
Journal:  Oncotarget       Date:  2017-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.